摘要
目的:了解临床分离变形杆菌及不动杆菌耐药性及分布情况。方法:采用回顾性调查的方法,对130株变形杆菌和277株不动杆菌的临床资料和药敏结果进行分析。结果:变形杆菌门诊标本比例高达33.8%;不动杆菌同样为门诊标本比例最高,为18.1%。变形杆菌尿液标本所占比例最高,为47.3%,不动杆菌以痰标本所占比例最高,为43%。除亚胺培南外,鲍曼不动杆菌对其他抗菌药物的耐药率均显著高于洛菲不动杆菌(P<0.05)。奇异变形杆菌在临床菌株中的分离比例远高于其他两种细菌。奇异变形杆菌对多种抗菌药物的耐药率都低于普通变形杆菌和潘尼变形杆菌。结论:变形杆菌主要来自泌尿系统感染,不动杆菌主要存在于呼吸系统感染,变形杆菌和不动杆菌属内各种细菌的耐药率有较大差别,临床治疗时应注意选用不同的抗菌药物。
Objective To analyze the drug resistance and distridution of clinical strains of proteus and acinetobaeter. Methods To retrospectively analyze the clinical data and drug resistant rates of proteus and acinetobacter. Results Proportion of out-patients＇ specimen added up to 33.8% in proteus and 18.1% in acinetobacter. Proportion of urine is highest, up to 47.3% in proteus and sputum up to 43% in acinetobacter. Except impenem, drug resistant rates of A.baumanii is significantly higher than that of A.lwoffii（P〈0.05）. Proportion of P.mirabilis is much higher than that of P.penneri and P.vulgaris and its＇ drug resistant rate is lower than that of P.penneri and P.vulgaris. Conclusion Proteus mainly come from urinary system infections and acinetobacter lie in respiratory system infections. Because drug resistant rates is different in each species of proteus or acinetobacter, we should select different antimicrobials in clinical therapy.
出处
《安徽卫生职业技术学院学报》
2006年第4期72-73,79,共3页
Journal of Anhui Health Vocational & Technical College
关键词
变形杆菌
不动杆菌
耐药
proteus
acinetobacter
drug resistance
